Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Jan 28, 2018 7:04pm

168 Views

Post# 27451099

RE:Staying in to get 20 or 30%....really?

Oh, no! It seems I have a dilemma here ... should I give more credence to the years of research I've seen on this board (literally ... *YEARS*) or to "itsnotSouvlakia", who joined the board on 1/8/2018 and who's entire due diligence seems to be "the FDA has not approved some applications."

Hmm, wonder which way I'll lean.

LT

itsnotSouvlakia wrote: What will the share price be in for some unknown reason there is failure on the FDA front?

30, 40 , 50 cents?

The FDA does say NO sometimes don't they??

The risk/reward scnario from here ( $8 ) is wildly scewed...and a NO would turn that into "wildly screwed"....simple reminder...do play...BUT NOT with grocery money

FWIW